Unlike in the U.S., scammers routinely place the NHS logo directly on their ads, alongside AI-generated NHS doctors and fabricated stories from NHS colleagues. One campaign tells a lengthy narrative from Daisy, 41, a nurse from Leeds, and her partner Tom, 46, described as ambulance workers who lost over 11 stone together. The story is crafted to be emotionally relatable for a UK audience: long shifts, vending machine meals, exhaustion, feeling unable to care for oneself
Using GLP-1 Patches in 2026: The TrimrX Expert Breakdown By 2026, the conversation around GLP-1 medications has moved far beyond the initial buzz
So the issue is not that nobody studies it because it is cheap. The issue is that the evidence we have supports modest metabolic effects, not drug-level obesity treatment effects
We have been increasingly hearing concerns from healthcare facilities about a class of medications known as glucagon-like peptide-1 receptor (GLP-1) agonists and their impact on patients receiving anesthesia for procedures